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A B S T R A C T
Objectives: To describe the epidemiological, clinical, and laboratory proﬁle of infective endocarditis (IE)
at a Brazilian tertiary care center, and to identify the predictors of in-hospital mortality.
Methods: Data from 62 patients who fulﬁlled the modiﬁed Duke’s criteria for IE during a seven-year
periodwere gathered prospectively. The Cox proportional hazardsmodel was used to identify predictive
factors for death.
Results: The mean age of patients was 45 years, and 39 patients (63%) were male. The median time from
admission to diagnosis was 15 days. Rheumatic heart disease was the predominant underlying heart
condition (39%), followed by valvular prosthesis (31%). Neurological complications were observed in 12
patients (19%). Echocardiography demonstrated one or more vegetations in 84% of cases. The infective
agent was identiﬁed in 65% of cases, and the most frequent causative agents were staphylococci (48%),
followed by streptococci (20%). The median duration of hospitalization was 39 days. Surgery was
performed during the acute phase of the IE in 53% of cases. The overall in-hospital mortality was 31%. On
multivariate analysis, vegetation length >13 mm remained the only independent predictor of in-
hospital mortality (hazard ratio 1.05 per millimeter, 95% conﬁdence interval 1.003–1.110, p = 0.038).
Conclusions: IE remains a severe disease affecting the young population in Brazil, and rheumatic heart
disease continues to be the most common underlying heart condition. Large vegetation size, assessed
early in the course of IE by transesophageal echocardiography, along with the clinical and
microbiological features, may predict in-hospital death.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In spite of the great advances made in diagnosis and treatment,
infective endocarditis (IE) remains a life-threatening condition
with a high mortality rate.1–4 However, its epidemiological
characteristics have changed signiﬁcantly over the past decades.5,6
In developed countries, the epidemiological features of IE are
changing as a result of increasing longevity, new predisposing
factors, and the higher frequency of nosocomial cases.5–7
Information on the proﬁle of IE in developing countries is
relatively scarce,8 but differences have been reported.9,10 This
fact emphasizes the necessity of carrying out regional studies in
order to describe the local characteristics of this disease, which
may help the prevention, diagnosis, and management of this
complex condition.* Corresponding author. Tel.: +55 31 34099746; fax: +55 31 34099437.
E-mail address: mcarmo@waymail.com.br (M.C.P. Nunes).
1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.06.024Therefore, we undertook the present study with the aim of
describing the clinical manifestations, echocardiographic and
laboratory ﬁndings, microbiological proﬁle, management strate-
gies, and in-hospital outcome of patients with IE who were
admitted to a tertiary care hospital in Brazil over a seven-year
period.
2. Methods
2.1. Patient population
From June 2001 to July 2008, 62 consecutive adult patients with
deﬁnite (n = 49) or possible (n = 13) IE according to the modiﬁed
Duke’s criteria,11 who were admitted to the University Hospital,
Federal University of Minas Gerais, Belo Horizonte, Brazil, were
included in the study. There were no exclusion criteria. Written
informed consent was obtained from all patients, as required by
the institutional ethics committee. Clinical evaluation, echocar-
diography, blood cultures, and routine laboratory tests were
performed within the ﬁrst 72 h of admission. For the participantsses. Published by Elsevier Ltd. All rights reserved.
Table 1
Patient baseline characteristics
Age (years), mean standard deviation 4517
Male, n (%) 39 (63%)
Duration of symptoms before diagnosis (days),
median (range)
15 (1–210)
Site of infection
Left-sided endocarditis, n (%)
Native mitral valve 14 (23%)
Native aortic valve 10 (16%)
Native mitro-aortic valves 2 (3%)
Prosthetic mitral valvea 10 (16%)
Prosthetic aortic valve 3 (5%)
Prosthetic mitro-aortic valves 6 (10%)
Right-sided endocarditis, n (%)
Tricuspid valve 3 (5%)
Pacemaker and ICD 12 (19%)
Otherb 2 (3%)
Previous infective endocarditis,c n (%) 14 (23%)
Rheumatic heart disease, n (%) 25 (40%)
Diabetes mellitus, n (%) 5 (8%)
Drugs use, n (%) 5 (8%)
Renal failure, n (%) 6 (10%)
Neurological complications, n (%) 12 (19%)
ICD, implantable cardioverter-deﬁbrillator.
a Biological and mechanical prostheses.
b Central venous catheters and hemodialysis.
c Including 24 patients with rheumatic diseases, 19 with prosthetic valve, nine
with mitral valve prolapse, seven with congenital heart diseases, and four with
degenerative valve diseases.
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into account.
2.2. Clinical and laboratory data
In accordance with a detailed protocol, clinical and laboratory
parameters were collected prospectively at diagnosis and during
hospitalization, until discharge from the hospital.
Brieﬂy, the clinical data recorded were: age, sex, previous heart
disease, intravenous drug abuse, HIV infection, diabetes mellitus
and other co-morbidities, fever and other constitutional manifes-
tations, peripheral stigmata of IE, splenomegaly, congestive heart
failure, stroke, and other embolic events. The antibiotic regimen,
aspects related to the surgical approach, and in-hospital outcome
were also recorded. Early surgery was deﬁned as valve replace-
ment or repair performed during the course of the antibiotic
therapy.
Complete blood count, C-reactive protein (CRP), serum
chemistry, and urine analysis comprised the routine laboratory
investigations that were recorded.
2.3. Echocardiography
Transthoracic (TTE) and/or transesophageal echocardiography
(TEE), as clinically indicated, were performed as previously
described.12 The presence of the following characteristics was
investigated: vegetation, abscess, new dehiscence, and new
moderate or severe valvular regurgitation. A vegetation was
deﬁned as an irregularly shaped echogenic mass attached to a
valve or myocardial surface.13 Measurements of the vegetation
length were performed in various planes, and the maximal length
was selected. An abscess was deﬁned as a thickened area or mass
with a heterogeneous echogenic or echolucent appearance.13 In
order to determine the severity of the valvular regurgitation,
semiquantitative analysiswas performedwith the use of color ﬂow
Doppler echocardiography.
2.4. Statistical analysis
Data were summarized as the means  standard deviation (SD),
medians and interquartile range, or proportions. The primary
outcome selected was in-hospital death. Baseline clinical, echocar-
diographic, and microbiological variables were tested as potential
predictors of in-hospital mortality. Variables associated with a p-
value of <0.10 under univariate analysis were included in a Cox
proportional hazards model in order to identify independent
characteristics associated with in-hospital death.
In order to investigate the association between the micro-
organism and in-hospital mortality from IE, the patients infected
with Staphylococcus aureus were compared with a second group,
which included all the other microbiological etiologies and
culture-negative IE cases.
Receiver operating characteristic (ROC) curve analysis was
performed to determine the optimal cut-off value of vegetation
length thatbestpredicted the end-point.A cumulative survival curve
for theoccurrenceof in-hospitaldeathwasperformedbytheKaplan–
Meiermethodandtestedbythe log-ranktest.Valuesofp< 0.05were
considered signiﬁcant. The analyses were performed using SPSS
statistical software (version 13.0; SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Clinical characteristics on admission
Baseline clinical features are shown in Table 1. The mean age of
patients was 45  17 years (range 15–76 years), and 39 patients(63%) were male. The median time between onset of symptoms and
diagnosis of IEwas 15 days (interquartile range 7–60 days; total range
1–210 days). The portal of entry and source of the bacteremia was
identiﬁed in 25 patients (40%); dental procedures predominated
(16%), followed by cutaneous infections (6%).
Fever was the most common symptom (80%) at the initial
evaluation. Other observed symptomswere anorexia (62%), weight
loss (46%), night sweats (34%), and myalgia (12%). Neurological
complications were present in 12 patients (19%); nine of them
were embolic events. The other sites of embolization were the
spleen (three cases), peripheral arteries (three cases), and kidney
(two cases).
Physical examination revealed a systolic murmur in 49 patients
(79%), and manifestations of heart failure were observed in 22
(35%). Other physical ﬁndings related to the IE included: Janeway
lesions (four cases), petechiae (one case), and Osler’s nodes (one
case).
The most common underlying heart disease was rheumatic
valvular disease, which was responsible for 39% of the cases of IE,
followed by valvular prosthesis (31%), and devices such as
pacemaker and implantable cardioverter-deﬁbrillator (19%). The
mitral valve was the most frequently involved, affecting 48% of
cases, followed by the aortic and tricuspid valves, which affected
21% and 5% of the cases, respectively. The site of infection could not
be identiﬁed in two cases. Anemia was present in 86% of the
patients, and the inﬂammatory parameters were constantly
elevated.
A pathogenic microorganism was isolated from blood cultures
in 40 cases (65%). The frequencies of the causative agents are
shown in Table 2. Staphylococci were the most common causative
organisms (48%), followed by streptococci, which were identiﬁed
in 20% of cases. Community-acquired methicillin-resistant S.
aureus was found in 13 patients (32%) and coagulase-negative
staphylococci in 15%. The nextmost common etiologic agentswere
enterococci (15%). Other pathogens including fungi accounted for
17% of the cases. Culture-negative endocarditis occurred in 22
patients (35%). Persistently negative blood cultures occurred as
commonly in the patients who received antibiotics prior to the
diagnosis of IE as in those who did not (p = 0.666).
Table 2
Etiologic agents of infective endocarditis
Microorganisms Episodes, number (%)
Streptococci (viridans, pyogenes) 8 (20%)
Staphylococci
Staphylococcus aureus 13 (32%)
Coagulase-negative staphylococci 6 (15%)
Enterococci 6 (15%)
Fungi 2 (5%)
Othera 5 (13%)
Negative-blood culturesb 22 (35%)
a Including HACEK group (Haemophilus, Actinobacillus, Cardiobacterium,
Eikenella, and Kingella; n=2), Escherichia coli (n=1), and polymicrobial (n=2).
b Deﬁnite infective endocarditis diagnosis using the clinical Duke’s criteria: one
major and three minor criteria or ﬁve minor criteria.
Table 3
Univariate predictors of in-hospital mortality
Variables Hazard ratio (95% conﬁdence
interval)
p-Value
Age (years) 0.985 0.957–1.013 0.297
Rheumatic heart disease 1.217 0.442–3.353 0.704
Cardiac device-related 0.627 0.204–1.928 0.415
Cardiac surgery 0.837 0.303–2.312 0.731
Prosthetic valve IE 1.932 0.628–5.942 0.251
Heart failure 1.113 0.493–2.511 0.796
C-reactive protein (mg/l)a 1.004 1.000–1.008 0.035
Leukocytes (cells/ml)b 1.874 1.061–3.310 0.030
Negative blood culture results 1.386 0.510–3.767 0.522
Staphylococcus aureus 3.393 1.110–10.372 0.032
Neurologic events 0.636 0.243–1.664 0.357
Abscesses 2.029 0.486–8.478 0.332
Vegetation length (mm) 1.055 1.003–1.110 0.038
Vegetation extentc 2.830 1.025–7.817 0.045
a Serum level at admission; the reference value was less than 5mg/l.
b Quartiles of the leukocytosis.
c Single versus multiple on a single leaﬂet, multiple leaﬂets or extending to
extravalvular structures.
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TTE was performed in 19 (31%) cases and TEE in 43 (69%). The
echocardiographic ﬁndings, speciﬁed according to the Duke’s
criteria, are shown in Table 1. A vegetation was evident in 84% of
the cases, and the majority of these were attached to a cardiac
valve (89%). Among the patients who died during hospitalization,
aortic or mitral valve vegetations were observed in 58% and right-
sided vegetations in 31% of the cases. The localization of the
vegetations did not predict mortality (p = 0.750).
Echocardiographic evidence of prosthetic valve dehiscence or
intracardiac abscess (Figure 1) was apparent in only a few cases
(six and three cases, respectively). New moderate or severe
regurgitation was observed in 20% of the cases, and its frequency
was similar between patients who survived and those who died in
hospital (p = 0.697).
3.3. Follow-up during antibiotic therapy
The mean ( SD) duration of hospital stay was 41 ( 30) days and
themedian (interquartile range) duration of hospital staywas 39 (24–
53) days, with a total range of 1–179 days. During this period, 19
patients died, corresponding to an overall mortality of 31%. Early
surgery was performed in 33 cases (53%) with a mean time from
admission to operation of 2 weeks. The indications for these
operations were: congestive heart failure (17 patients (27%)),
persistent signs of septicemia despite antibiotic treatment (14
patients (22%)), and recurrent embolization (two patients (3%)).
Patients with device-associated IE had the device removed after a
week of antibiotic treatment. In-hospital mortality rates were not
signiﬁcantly different between the group of patients who underwent
cardiac surgery and those who did not (31% and 29%, respectively;Figure 1. Transesophageal long-axis view showing a small abscess at the mitral–
aortic intervalvular ﬁbrosa. The abscess is the abnormal echolucent area within the
intervalvular ﬁbrosa.p = 0.867). The principal causes of death were severe heart failure,
multiorgan failure, and septic shock.
Factors affecting mortality in the univariate analysis were: S.
aureus infection, high CRP levels, high white blood cell count, long
vegetation length, and multivalvular involvement (Table 3). After
adjusting for age, presence of abscess, multivalvular involvement,
and S. aureus infection, vegetation length remained as the only
independent predictor of in-hospital mortality on multivariate
analysis (hazard ratio (HR) 1.05 per millimeter, 95% conﬁdence
interval (CI) 1.003–1.110, p = 0.038). According to the ROC curve,
vegetation length >13 mm is associated with the best predictive
value, with a sensitivity of 88% and speciﬁcity of 75% (area under
the curve: 0.797) (Figure 2). A Kaplan–Meier curve was con-
structed using the 13 mm-vegetation length as the cut-off value
(Figure 3).
4. Discussion
The present study provides several important insights into IE in
the current era at a referral hospital in a developing country.Figure 2. Receiver operating characteristics (ROC) curves for vegetation length at
diagnosis of infective endocarditis.
Figure 3. Kaplan–Meier curves demonstrating in-hospital survival according to
vegetation length.
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techniques, antibiotic therapy, and the surgical approach, IE is still
associatedwith a severe outcome. The overall in-hospitalmortality
rates for both native valve and prosthetic valve IE remain high.1–
4,14 In our study, the in-hospital mortality was 31%, which is
slightly higher than that observed in other countries,4,7,15–18
including some developing countries.8,19 We hypothesize that this
difference could be explained, at least in part, by the high risk
proﬁle of the patients admitted to our institution, such as cases of
late diagnosis, which already have complications at admission, the
high prevalence of patients with valve prostheses, and the high
proportion of IE involving staphylococci. It is well known that the
clinical features of IE substantially differ between patients from
referral centers and those seen in primary-care centers.20,21
According to our study, rheumatic valvular disease remains the
most common underlying heart disease. As a result, our patients
were younger, which is consistent with previously published
studies fromdeveloping countries.9,18,19 In contrast, literature data
have demonstrated a gradual increase in the mean age of IE
patients in developed countries,8,22,23 which is largely attributed to
both the high prevalence of undiagnosed degenerative valve
disease4 and the increased use of invasive procedures and
implanted medical devices.22 Similar to the results of other
studies, men were found to be affected more often than women
(male:female ratio, 1.7:1).14
Our results conﬁrmmany of the clinical features of IE occurring
in other parts of theworld. For example, most of our cases involved
native valves, and the mitral valve was the most frequently
affected, followed by the aortic valve. Fever was the most common
presenting feature in our cohort, as observed by others.9,14,18,19 As
described previously, in most of our cases some clinical
manifestations were present for weeks before the diagnosis. Other
investigators have reported an even more prolonged duration of
symptoms.24 The long duration of hospitalization in our series is
similar to that reported in other studies,17 and denotes the
important cost burden. Peripheral manifestations of IE have been
decreasing as a result of early diagnosis and therapy.4
In our study cohort, valve surgery was carried out in a large
proportion of patients during antibiotic therapy, which is in
accordance with the new trends in IE treatment, i.e., early valve
surgery.7,17,19 However, the frequency of surgery in our series was
considerably higher than that reported in some recent studies from
other parts of the world.8,9 These numbers reﬂect not only a goodadherence to modern care standards, aiming to further integrate
surgery in the initial management strategy of IE, but also the
particular severity in our patients. Although the highest risk
patients are those who are generally referred for surgical
intervention, surgery was not found to be associated with
mortality in our investigation. Further studies are needed to
evaluate whether early surgical intervention for patients at higher
risk of death will improve outcome.16
Theproportionofnegativebloodcultureswashigh inour seriesat
35%, which is far beyond the 10% rates reported in recent
publications.8,17 The prevalence of culture-negative IE is more
frequent indevelopingcontries.9,10,25,26This facthasbeenascribedto
three major reasons: previous administration of antimicrobial
agents, inadequate microbiological techniques, and infection with
highly fastidious bacteria or non-bacterial pathogens.25,26 Although
the use of antibiotics without prescription is a common practice in
Brazil, our results suggest that this factdidnotplayamajor role in the
high rate of negative blood cultures in our study; however, it is not
possible to completely rule out this possibility in some of our cases.
The culture technique, volume of blood, number of blood cultures,
and meticulous care in obtaining the blood are important determi-
nants of the accuracy of blood culture results. Although a standard
blood culture system is used at our institution, we cannot entirely
exclude the possibility of some oversights, such as a prolonged
specimen transport time. Finally, fastidious microorganisms were
probably responsible for some negative blood cultures in our series.
As reported recently, staphylococcal species have emerged,
along with streptococci, as the major causative microorgan-
isms.7,17,21 An acceptable explanation for this could be the
increasing access to medical facilities and the expanding use of
invasive procedures in Brazil, favored by economic development.
Prosthetic valve endocarditis has accounted for 7–25% of cases
of IE in most developed countries.14 In our study, the frequency of
IE involving prosthetic valves was around 30%, probably reﬂecting
an increase in surgical treatment of rheumatic valvular heart
disease. Prosthetic valve endocarditis accounted for over 20% of all
IE cases in a recent prospective, multicenter, international
registry,7 reﬂecting a considerably higher proportion in compar-
isonwith reports from the last decade,27 but similar to the ﬁndings
of a one-year survey of IE in France, whichwas published ﬁve years
before.17 Altogether these data point towards a progressive
increase in the frequency of prosthetic valve endocarditis. In
addition, the high sensitivity of TEE probably enhanced the
detection of prosthetic valve endocarditis in our series.
The in-hospital mortality and early surgical intervention rates
were similar for native valve and prosthetic valve IE in our
investigation. Although prosthetic valve IE is associatedwith a very
high mortality rate, only ﬁve of our patients presented early-
prosthetic valve IE, which is caused by more virulent organisms
and has a worse outcome.
Some studies have attempted to evaluate the prognostic role of
echocardiography in IE, focusing on the association between
vegetation size and risk of embolic events.16,28,29 However, the
relationship between echocardiographic ﬁndings and survival
remains undeﬁned. The speciﬁc echocardiographic ﬁndings of the
Duke’s criteria assessed early in the course of IE were not
predictive of in-hospital death in the study by Chu et al.15 These
results suggest that echocardiographymay have greater diagnostic
utility than prognostic signiﬁcance in early IE. One challenging
aspect of this disease is the dynamic nature of its clinical and
echocardiographic ﬁndings during the active phase.
Interestingly, we found, in the multivariate analysis, that
vegetation length >13 mm was a predictor of in-hospital death,
even after adjustment for the other predictors. Older series failed
to demonstrate a prognostic value of the presence and/or size of
the vegetation, probably because of both the small number of
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in agreement with the recent prospective multicenter study by
Thuny et al.,16 which showed a direct relationship between the size
of the vegetation andmortality. Moreover, the results of that study
demonstrated that large vegetations (>10 mm) and/or high
vegetation mobility were associated with an increased embolic
risk. Similarly, with the systematic use of TEE, Hill et al.29 observed
that vegetation length >10 mm was independently associated
with six-month mortality. Thus, our ﬁndings and the above
literature data suggest that echocardiography, performed early in
the course of IE, may have a prognostic value. Along with baseline
clinical and microbiological features, the assessment of vegetation
characteristics may contribute to the identiﬁcation of those
patients who are at high risk of death. However, these aspects
need further investigation.
4.1. Study limitations
Our study group was relatively small and included patients
from a single large tertiary-care center, to which many patients
with IE were referred from other hospitals. These facts may have
caused selection bias resulting in limitations to the generalization
of the results. TEE was performed in 69% of the cohort; more
frequent use of this method could have inﬂuenced the results
related to the echocardiographic ﬁndings and their association
with outcome. Furthermore, the small sample size could have
exerted some inﬂuence on the results of the multivariate analysis.
Thus, studies including a larger number of events are necessary to
conﬁrm (or not) our ﬁndings regarding the independent predictors
of in-hospital death.
4.2. Conclusions
Our study demonstrates that IE remains a severe disease
affecting a young population in Brazil, and is associated with high
in-hospital mortality. Rheumatic heart disease continues to be the
most common underlying heart condition. Survival was similar for
patients with native valve or prosthetic valve IE, and also for
patients who underwent early surgery or did not. Speciﬁc
echocardiographic ﬁndings, particularly the vegetation size,
assessed early in the course of IE, along with clinical and
microbiological features, may predict in-hospital death. Recogni-
tion of these factors could improve risk stratiﬁcation and,
therefore, the selection of patients for more intensive treatment.
Conﬂict of interest: We declare that we have no conﬂicts of
interest.
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